This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Although more pharmaceuticalcompanies are tailoring their business models to focus on low-income countries, a new analysis finds that overall industry efforts remain limited and patient access continues to suffer as a result.
Some of the largest pharmaceuticalcompanies in the U.S. This unprecedented move launches a new dystopic era: pharmaceuticalcompanies as health care provider, no pesky physician middlemen needed. Want to self-prescribe a prescription drug? No problem!
The genetic data, cross-referenced with the patients’ de-identified medical records, will be available for purchase for researchers and life sciences companies. Pharmaceuticalcompany Regeneron has invested $119.5
We chat about how pharmaceuticalcompanies are navigating a looming patent cliff. We also talk about yet another obesity startup and a failed study from Google’s secretive anti-aging company Calico. And what are the hosts’ New Year’s resolutions? Read the rest…
During an April 2023 inspection at Raptim facilites in Nava Mumbai, India, FDA inspectors found “objectionable conditions” that led them to conclude the company falsified data in testing for multiple subjects and samples across multiple studies, according to a letter sent last week to the pharmaceuticalcompanies.
lawmaker described as possibly the “largest tax-dodging scheme” by a pharmaceuticalcompany in history, Pfizer sold $20 billion in medicines to U.S. In what one U.S.
Four months ago, a small pharmaceuticalscompany bought a medicine used to combat a rare growth disorder in children and quickly raised the list price by 150%. But the company, Eton Pharmaceuticals, argues there is no other way to keep its treatment on the market and make a profit.
Drug patents are a form of intellectual property protection that grants pharmaceuticalcompanies exclusive rights to manufacture, sell, and profit from their innovations for a set period. This exclusivity is the lifeblood of the industry, allowing companies to recoup their substantial R&D investments and fund future discoveries.
Parliament is calling for regulators to audit pharmaceuticalcompanies that have made misleading statements to the public about their Covid-19 vaccines. A member of the U.K. And the move comes after Moderna was chastised for the second time in five months by a U.K.
Effective management of drug patent portfolios is crucial for pharmaceuticalcompanies to maintain market exclusivity, protect revenue streams, and drive innovation. A robust patent strategy aligned with business goals is essential for maximizing value and staying competitive in the pharmaceutical landscape.
Continued strategic focus on North America: US market accounts for anywhere between 30 per cent to 60 per cent of annual revenues for Leading Pharmaceuticalcompanies in India. Companies will continue to acquire leadership capabilities with focus on these markets.
Once these common facilities are created, they are expected to provide access to common facilities to around 1,300 existing pharmaceutical units, besides catalysing the augmentation of capacities at these clusters through the setting up of new pharmaceutical units and expansion of existing units.
But what drives this complex system, and how do pharmaceuticalcompanies ensure that their drug names meet the strict guidelines set by regulatory agencies? At the heart of pharmaceutical drug naming is the International Nonproprietary Name (INN) system.
More than a decade ago, Ken Mandl was on a call with a pharmaceuticalcompany and the leader of a social network for people with diabetes. The drug maker was hoping to use the platform to encourage its members to get a certain lab test. The test could determine a patient’s need for a helpful drug.
This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceuticalcompanies seeking to introduce generic drugs into the Japanese market.
In India, pharmaceuticalcompanies responded to global environmental concerns and government mandates by adopting greener manufacturing techniques. Indian pharmaceuticalcompanies have specialised in reverse-engineering complex medicines and producing biosimilars as alternatives to costly biologics.
It is therefore essential that the government revisits the 200 per cent weighted tax benefit on R&D spending in order to encourage more pharmaceuticalcompanies to invest in innovative research. However, massive R&D expenditure is necessary to drive the next generation of discoveries.
Read on to learn how MRAs are changing the game for generic drug approvals and what this means for patients, pharmaceuticalcompanies, and regulatory bodies alike: [link] #MRAs #GenericDrugs #RegulatoryReform" But what exactly are MRAs, and how can they be leveraged to drive innovation and access to life-saving treatments?
And reminiscent of a modern-day gold rush, there is now a headlong race among a growing number of pharmaceuticalcompanies to determine how many other maladies the drugs may be capable of treating.
Between September and October 2024, EY-P and OPPI undertook primary research * consulting top CXOs from leading Indian and global multinational pharmaceuticalcompanies, to understand their perspective on the pivotal growth areas for the Indian pharma industry.
The pharmaceutical industry is heavily reliant on patents to protect intellectual property and maintain market exclusivity. However, with the increasing competition from generic and biosimilar manufacturers, patent invalidity claims have become a significant challenge for pharmaceuticalcompanies.
Global pharmaceuticalcompanies have played a pivotal role in transforming the healthcare sector in India. Approximately 70 per cent of global pharmaceuticalcompanies are expected to achieve annual growth of over 10 per cent in India over the next five years.
One of the practical challenges discussed was the implementation of personal and material airlocks in small pharmaceuticalcompanies, where the panel addressed space constraints and suggested viable alternatives such as dynamic pass boxes and modular cubicles for material transfer.
The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48 As a result, many companies are turning to integrated CDMOs to simplify their outsourcing processes and improve efficiency. billion in 2022 and is expected to grow at a compound annual growth rate of 5.3%
Unlike traditional consumer brands, pharmaceuticalcompanies face unique challenges on social media, including strict regulations, compliance concerns, and the need for factual accuracy. For pharmaceuticalcompanies, this can provide insights into public perception of drug launches, patient experiences, and industry discussions.
Some pharmaceuticalcompanies have already adopted continuous manufacturing processes for their drugs, significantly reducing production times and improving quality control. The industrial approach must be modernised if long-term success is to be achieved.
The European Commission on Friday unconditionally approved a controversial deal in which Novo Holdings, the parent company of Novo Nordisk, one of the largest pharmaceuticalcompanies, would pay $16.5 billion for Catalent, a leading contract drug manufacturer.
With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceuticalcompanies and healthcare brands are allocating more resources to advertising in 2025. But what is driving this surge in healthcare ad spend?
In a brief statement , the Belgian Competition Authority alleged that Roche offered financial incentives to hospitals between 2017 and 2020 to deter them from considering competitive bids from other pharmaceuticalcompanies that could supply similar medicines.
Ever-increasing drug discovery and development timelines are a multiscale issue causing delays in patient access to medicines and increasing costs for pharmaceuticalcompanies.
It combines advanced technology with user-friendly features, empowering pharmaceuticalcompanies to enhance their efficiency and adaptability, giving them a competitive edge.” Engineered in Germany and manufactured in India, its global design represents the perfect balance of design expertise and local manufacturing excellence.
Ind-Ra has maintained a Stable rating Outlook on 67 per cent of its rated pharmaceuticalcompanies in FY25, citing a low leverage ratio and adequate liquidity, and expects limited rating movements in the sector. Most large pharmaceuticalcompanies rated by Ind-Ra fall into high investment-grade categories.
Dr. Shah emphasised the importance of quality-driven processes and the need to simplify operational systems within pharmaceuticalcompanies to achieve seamless compliance with Revised Schedule M.
Key Stakeholders in Pharmaceutical Negotiations Successful negotiations in the pharmaceutical industry require a deep understanding of the various stakeholders involved. These may include: Pharmaceuticalcompanies (big pharma and biotech firms) Contract research organizations (CROs) Regulatory bodies (e.g.,
Access to cheaper alternatives and low enrollment prompted the company to remove the medicine — along with the HIV medicines Emtriva, Tybost, and Complera — from its patent assistance program next month, according to an Oct. 8 letter that announced the move and that has not been widely reported.
Pharmaceuticalcompanies can leverage these tools to gather real-world evidence, personalize treatments, and improve the patient experience. Remote monitoring, mobile apps, and AI-powered virtual assistants are enhancing patient engagement, adherence, and outcomes.
The biologics market is expected to grow to more than $670 billion(iv) by 2030, and for pharmaceuticalcompanies developing these complex drugs, the BD Libertas Wearable Injector offers a customisable, patient-centric solution.
These programs provide a solid foundation in both the scientific principles and practical aspects of the pharmaceutical industry, preparing students to meet the ever-evolving demands of the field. One way universities foster this preparation is through partnerships with pharmaceuticalcompanies.
By partnering with a CDMO, companies can benefit from these resources without having to invest in their own infrastructure. Collaborative Approach The regulatory process is inherently collaborative, and CDMOs work closely with pharmaceuticalcompanies to navigate the regulatory pathway.
Alembic Pharmaceuticals announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Brexpiprazole Tablets, 0.25 mg, 1 mg, 2 mg, 3 mg and 4 mg, of Otsuka PharmaceuticalCompany, Ltd. mg, 1 mg, 2 mg, 3 mg and 4 mg.
The programme saw over 250 attendees, including professionals from MSMEs and larger pharmaceuticalcompanies, regulatory authorities, and academic institutions. Teachers and postgraduate and PhD students specialising in Pharmaceutics and Pharmaceutical Analysis also participated.
The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to streamline the drug development and manufacturing process. CDMOs provide a wide range of services that cater to the diverse needs of pharmaceuticalcompanies, from early-stage development to commercial manufacturing.
HRV Global Life Sciences, a virtual integrated pharmaceuticalcompany, delivers the first shipment of anti-diabetic medications to Mendoza, Argentina. The consignment of USFDA-qualified Metformin (1000mg) was received by the province of Mendoza for distribution in the public health system.
government agency warned Sanofi that it faces sanctions over plans to change the way payments are made to most hospitals participating in a drug discount program, the third time in recent months that a major pharmaceuticalcompany has been threatened with such a step , STAT tells us.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content